Przejdź do
M2901
Molsidomine
Synonim(y):
N-(Ethoxycarbonyl)-3-(4-morpholino)sydnone imine, SIN-10
Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.
Informacje o tej pozycji
Wzór empiryczny (zapis Hilla):
C9H14N4O4
Numer CAS:
Masa cząsteczkowa:
242.23
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
247-207-4
MDL number:
storage temp.
2-8°C
SMILES string
CCOC(=O)N=C1O[N-][N+](=C1)N2CCOCC2
InChI
1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3/b10-8-
InChI key
XLFWDASMENKTKL-NTMALXAHSA-N
Application
Molsidomine has been used as nitric oxide (NO)-releasing vasodilator to study the effect of NO on angiostatin production in aging rat kidneys.[1]
Biochem/physiol Actions
Orally active, long acting vasodilator; antianginal; converted by the liver to the active metabolite, SIN-1
Molsidomine is an effective vasodilator[2] and a long-lasting nitric oxide (NO) donor.[1] It is a pro-drug that is enzymatically decarboxylated to form 3-morpholinosydnone imine (SIN-1) in the liver. Molsidomine is used as an anti-anginal agent and possesses antioxidant properties. It may be used to treat cisplatin-induced oxidative stress in the liver tissue.[2] Molsidomine has also been used during angina pectoris, heart failure, and after myocardial infarction.
Ta strona może zawierać tekst przetłumaczony maszynowo.
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
Istvan Kovanecz et al.
The journal of sexual medicine, 9(11), 2814-2826 (2012-09-15)
Long-term daily administration of phosphodiesterase type 5 (PDE5) inhibitors in the rat prevents or reverses corporal veno-occlusive dysfunction (CVOD) and smooth muscle cell (CSMC) loss and fibrosis, in both aging and bilateral cavernosal nerve resection (BCNR) models for erectile dysfunction.
Jerzy Sacha et al.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 17(3), 286-290 (2012-07-24)
Myocardial ischemia during coronary spasm may generate malignant ventricular arrhythmias. The J-wave pattern was suggested to be a marker of a disorder associated with life-threatening arrhythmias. We report the case of a patient with vasospastic angina and J-wave pattern in
Molsidomine
Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (2016)
Numer pozycji handlu globalnego
| SKU | NUMER GTIN |
|---|---|
| M2901-5G | 04061833428528 |
| M2901-500MG | 04061833435120 |